COVID‐19 severity from Omicron and Delta SARS‐CoV‐2 variants

Fast and accurate short read alignment with Burrows-Wheeler transform

Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607 · see citing works

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Rambaut, A., Holmes, E. C., O’Toole, Á., Hill, V., McCrone, J. T., Ruis, C., du Plessis, L., & Pybus, O. G. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0770-5 · Cited by 2,543 · see citing works

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

Viana, R. P. E. S., Moyo, S. M., Amoako, D. G., Tegally, H., Scheepers, C., Althaus, C. L., Anyaneji, U. J., Bester, P. A., Boni, M. F., Chand, M., et al. (2022) · Nature · doi:10.1038/s41586-022-04411-y · Cited by 1,653 · see citing works

SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection

Cele, S., Jackson, L., Khoury, D. S., Khan, K., Moyo-Gwete, T., Tegally, H., San, J. E., Cromer, D., Scheepers, C., Amoako, D., et al. (2021) · doi:10.1101/2021.12.08.21267417 · Cited by 1,333 · see citing works

Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool

O’Toole, A. N., Scher, E., Underwood, A. P., Jackson, B., Hill, V., McCrone, J. T., Colquhoun, R., Ruis, C., Abudahab, K., Taylor, B. E. W., et al. (2021) · Virus Evolution · doi:10.1093/ve/veab064 · Cited by 1,079 · see citing works

Nextclade: clade assignment, mutation calling and quality control for viral genomes

Aksamentov, I., Roemer, C., Hodcroft, E. B., & Neher, R. A. (2021) · The Journal of Open Source Software · doi:10.21105/joss.03773 · Cited by 1,061 · see citing works

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

Wolter, N., Jassat, W., Walaza, S., Welch, R., Moultrie, H., Groome, M., Amoako, D. G., Everatt, J., Bhiman, J. N., Scheepers, C., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00017-4 · Cited by 1,041 · see citing works

An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar

Grubaugh, N. D., Gangavarapu, K., Quick, J., Matteson, N. L., de Jesus, J. G., Main, B. J., Tan, A. L., Paul, L. M., Brackney, D. E., Grewal, S., et al. (2019) · Genome biology · doi:10.1186/s13059-018-1618-7 · Cited by 979 · see citing works

rms: Regression Modeling Strategies

Harrell, F. E. (2009) · doi:10.32614/cran.package.rms · Cited by 477 · see citing works

Ultrafast Sample placement on Existing tRees (UShER) enables real-time phylogenetics for the SARS-CoV-2 pandemic

Turakhia, Y., Thornlow, B. P., Hinrichs, A. S., Maio, N. D., Gozashti, L., Lanfear, R., Haussler, D. H., & Corbett-Detig, R. B. (2021) · Nature Genetics · doi:10.1038/s41588-021-00862-7 · Cited by 412 · see citing works

Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California

Lewnard, J. A., Hong, V. X., Patel, M. M., Kahn, R. J., Lipsitch, M., & Tartof, S. Y. (2022) · Nature Medicine · doi:10.1038/s41591-022-01887-z · Cited by 382 · see citing works

Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission

Shrestha, L. B., Foster, C. S. P., Rawlinson, W. D., Tedla, N. T., & Bull, R. A. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2381 · Cited by 469 · see citing works

Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study

Evans, R. A., Dube, S., Lu, Y., Yates, M., Arnetorp, S., Barnes, E. J., Bell, S., Carty, L., Evans, K., Graham, S., et al. (2023) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100747 · Cited by 206 · see citing works

Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis

Relan, P., Motaze, N. V., Kothari, K. U., Askie, L. M., de Waroux, O. L. P., Kerkhove, M. D. V., Diaz, J. V., & Vijayaraghavan, B. K. T. (2023) · BMJ Global Health · doi:10.1136/bmjgh-2023-012328 · Cited by 121 · see citing works

Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients

Hu, F.-H., Jia, Y., Zhao, D., Fu, X.-L., Zhang, W., Tang, W., Hu, S.-Q., Wu, H. J., Ge, M.-W., Du, W., et al. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.03.017 · Cited by 89 · see citing works

Long COVID following Omicron wave in Eastern India—A retrospective cohort study

Arjun, M. C., Singh, A. K., Roy, P., Ravichandran, M., Mandal, S., Pal, D., Das, K., Gajjala, A., Venkateshan, M., Mishra, B., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28214 · Cited by 72 · see citing works

COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants

Hernández‐Aceituno, A., García-Hernández, A., & Larumbe‐Zabala, E. (2023) · Infectious Diseases Now · doi:10.1016/j.idnow.2023.104688 · Cited by 71 · see citing works

Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape

Bhattacharya, M., Chatterjee, S., Sharma, A. R., Lee, S., & Chakraborty, C. (2022) · Folia Microbiologica · doi:10.1007/s12223-022-01001-3 · Cited by 48 · see citing works

COVID-19 Variants in Critically Ill Patients: A Comparison of the Delta and Omicron Variant Profiles

Corriero, A., Ribezzi, M., Mele, F., Angrisani, C., Romaniello, F., Daleno, A., Loconsole, D., Centrone, F., Chironna, M., & Brienza, N. (2022) · Infectious Disease Reports · doi:10.3390/idr14030052 · Cited by 40 · see citing works

“It was almost like it’s set up for people to fail” A qualitative analysis of experiences and unmet supportive needs of people with Long COVID

McNabb, K. C., Bergman, A., Smith-Wright, R., Seltzer, J. L., Slone, S., Tomiwa, T., Alharthi, A., Davidson, P. M., Commodore-Mensah, Y. Y., & Ogungbe, O. (2023) · BMC Public Health · doi:10.1186/s12889-023-17033-4 · Cited by 37 · see citing works

Internet-based Surveillance Systems and Infectious Diseases Prediction: An Updated Review of the Last 10 Years and Lessons from the COVID-19 Pandemic

McClymont, H., Lambert, S. B., Barr, I., Vardoulakis, S., Bambrick, H., & Hu, W. (2024) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-024-00272-y · Cited by 39 · see citing works

Vaccine effectiveness against Delta, Omicron BA.1, and BA.2 in a highly vaccinated Asian setting: a test-negative design study

Tan, C. Y., Chiew, C. J., Pang, D., Lee, V. J., Ong, B. K. C., Lye, D. C., & Tan, K. B. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.08.002 · Cited by 30 · see citing works

Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France

Tamandjou Tchuem, C. R., Auvigne, V., Vaux, S., Montagnat, C., Paireau, J., Monnier Besnard, S., Gabet, A., Benhajkassen, N., Le Strat, Y., Parent Du Chatelet, I., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.02.062 · Cited by 27 · see citing works

Comparative hospitalization risk for SARS‐CoV‐2 Omicron and Delta variant infections, by variant predominance periods and patient‐level sequencing results, New York City, August 2021–January 2022

Greene, S. K., Levin‐Rector, A., Kyaw, N. T. T., Luoma, E., Amin, H., McGibbon, E., Mathes, R. W., & Ahuja, S. D. (2022) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13062 · Cited by 28 · see citing works

Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM study

Quint, J. K., Dube, S., Carty, L., Yokota, R. T. C., Bell, S., Turtle, L. C. W., Lu, Y., Evans, K., Justo, N., Harley, M., et al. (2025) · Journal of Infection · doi:10.1016/j.jinf.2025.106432 · Cited by 27 · see citing works

COVID‐19 vaccinations and rates of infections, hospitalizations, ICU admissions, and deaths in Europe during SARS‐CoV‐2 Omicron wave in the first quarter of 2022

Rzymski, P., Kasianchuk, N., Sikora, D., & Poniedziałek, B. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28131 · Cited by 19 · see citing works

Impact of COVID infection on lung function test and quality of life

Toh, M. R., Teo, Y. R., Poh, L. C. R., Tang, Y., Soh, R. Y., Sharma, K., Kalyanasundaram, G., & Poh, K. C. (2023) · Scientific Reports · doi:10.1038/s41598-023-43710-w · Cited by 19 · see citing works

India’s Multi-Sectoral Response to Oxygen Surge Demand during COVID-19 Pandemic: A Scoping Review

Mirza, M., Verma, M., Sahoo, S. S., Roy, S., Kakkar, R., & Singh, D. K. (2023) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_665_22 · Cited by 18 · see citing works

A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19

Luo, J., Zhang, Z., Song, Z., & Gao, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076369 · Cited by 18 · see citing works

Multidimensional analysis of immune cells from COVID-19 patients identified cell subsets associated with the severity at hospital admission

Gil-Manso, S., Herrero-Quevedo, D., Carbonell, D., Martínez‐Bonet, M., Bernaldo-de-Quirós, E., Kennedy-Batalla, R., Gallego-Valle, J., López-Esteban, R., Blázquez‐López, E., Miguéns-Blanco, I., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011432 · Cited by 16 · see citing works

Advanced biopolymer nanocomposites for real-time biosurveillance and defense against antimicrobial resistance and viral threats

Alzahrani, A. S., Alamry, K. A., & Hussein, M. A. (2025) · RSC Advances · doi:10.1039/d5ra04504e · Cited by 17 · see citing works

Longitudinal study across SARS-CoV-2 variants identifies transcriptionally active microbes (TAMs) associated with Delta severity

Devi, P., Kumari, P., Yadav, A., Tarai, B., Budhiraja, S., Shamim, U., & Pandey, R. (2023) · iScience · doi:10.1016/j.isci.2023.107779 · Cited by 9 · see citing works

Nanobodies: COVID-19 and Future Perspectives

Valenzuela, G., Miranda-Chacón, Z., Salinas-Rebolledo, C., Jara, R., Cuevas, A., Berking, A., & Rojas‐Fernández, A. (2022) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2022.927164 · Cited by 13 · see citing works

Increased psychological distress among young people before and during the fifth wave of COVID-19 after two years of pandemic in Hong Kong: a 6-month longitudinal study

Wong, S. M. Y., Chen, E. Y. H., Suen, Y. N., Ho, W. K. O., Chan, S. K. W., Lee, E. H. M., Chan, K., Lui, S. S. Y., Wong, M. T., & Hui, C. L. M. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04933-3 · Cited by 13 · see citing works

Understanding the leading indicators of hospital admissions from COVID-19 across successive waves in the UK

Mellor, J., Overton, C. E., Fyles, M., Chawner, L. R., Baxter, J., Baird, T., & Ward, T. (2023) · Epidemiology and Infection · doi:10.1017/s0950268823001449 · Cited by 13 · see citing works

True prevalence of long COVID in children: a narrative review

Esposito, S., Deolmi, M., Ramundo, G., Puntoni, M., Caminiti, C., & Principi, N. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1225952 · Cited by 13 · see citing works

Citizen Stance towards Mandatory COVID-19 Vaccination and Vaccine Booster Doses: A Study in Colombia, El Salvador and Spain

Iguacel, I., Álvarez-Najar, J. P., Vásquez, P. D. C., Alarcón, J., Orte, M. Á., Samatán, E., & Martínez‐Jarreta, B. (2022) · Vaccines · doi:10.3390/vaccines10050781 · Cited by 12 · see citing works

A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects

Dotiwala, F., & Upadhyay, A. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940715 · Cited by 11 · see citing works

Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity

Razonable, R. R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1397040 · Cited by 11 · see citing works

In vivo evaluation of Andrographis paniculata and Boesenbergia rotunda extract activity against SARS-CoV-2 Delta variant in Golden Syrian hamsters: Potential herbal alternative for COVID-19 treatment

Kongsomros, S., Boonyarattanasoonthorn, T., Phongphaew, W., Kasorndorkbua, C., Sunyakumthorn, P., Im‐Erbsin, R., Lugo‐Roman, L. A., Kongratanapasert, T., Paha, J., Manopwisedjaroen, S., et al. (2024) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2024.05.004 · Cited by 10 · see citing works

Homologous and Heterologous Boosting of the Chadox1-S1-S COVID-19 Vaccine With the SCB-2019 Vaccine Candidate: A Randomized, Controlled, Phase 2 Study

Clemens, S. A. C., Milan, E. P., Sprinz, E., Neto, J. C., Pacciarini, F., Li, P., Chen, H., Smolenov, I. V., Pollard, A. J., & Clemens, R. L. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac418 · Cited by 10 · see citing works

COVID-19 Severity and Mortality after Vaccination against SARS-CoV-2 in Central Greece

Samara, A. A., Boutlas, S., Janho, M. B., Gourgoulianis, K. I., & Sotiriou, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091423 · Cited by 10 · see citing works

Characteristics, outcome, duration of hospitalization, and cycle threshold of patients with COVID-19 referred to four hospitals in Babol City: a multicenter retrospective observational study on the fourth, fifth, and sixth waves

Sadeghi, F., Halaji, M., Shirafkan, H., Pournajaf, A., Ghorbani, H., Babazadeh, S., Ezami, N., Fallhpour, K., Fakhraie, F., Gorjinejad, S., et al. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-023-08939-w · Cited by 10 · see citing works

Development of lab score system for predicting COVID-19 patient severity: A retrospective analysis

Sarkar, A., Sanyal, S. C., Majumdar, A. S., Tewari, D. N., Bhattacharjee, U., Pal, J., Chakrabarti, A. K., & Dutta, S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273006 · Cited by 9 · see citing works

The Clinical Course and Outcomes of Patients Hospitalized Due to COVID-19 during Three Pandemic Waves in Poland: A Single Center Observational Study

Bieńkowski, C., Kowalska, J. D., Paciorek, M., Wasilewski, P., Uliczny, P., Garbacz‐Łagożna, E., Pihowicz, A., Mrozińska, M., Dyda, T., Makowiecki, M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247386 · Cited by 7 · see citing works

Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey

Mediavilla, J. R., Lozy, T., Lee, A., Kim, J. S., Kan, V. W., Titova, E., Amin, A., Zody, M. C., Corvelo, A., Oschwald, D. M., et al. (2023) · Viruses · doi:10.3390/v15081699 · Cited by 7 · see citing works

Moral characteristics predicting COVID ‐19 vaccination

Zher‐Wen, Zhen, S., & Yu, R. (2023) · Journal of Personality · doi:10.1111/jopy.12892 · Cited by 6 · see citing works

Enhancing SARS-CoV-2 Lineage Surveillance through the Integration of a Simple and Direct qPCR-Based Protocol Adaptation with Established Machine Learning Algorithms

Aksenen, C. F., FERREIRA, D. V., Jerônimo, P. M. C., Costa, T. D. O., de Souza, T. C., Lino, B. M. N. S., de Farias, A. A., & Miyajima, F. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04492 · Cited by 6 · see citing works

Differences in leucocytes and inflammation-based indices among critically ill patients owing to SARS-CoV-2 variants during several successive waves of COVID-19 pandemic

Jemaa, A. B., Oueslati, R., Guissouma, J., Ghadhoune, H., Ali, H. B., Allouche, H., Trabelsi, I., Samet, M., & Brahmi, H. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110836 · Cited by 6 · see citing works

Differential platelet activation through an interaction with spike proteins of different SARS-CoV-2 variants

Sevilya, Z., Kuzmina, A., Cipok, M., Hershkovitz, V., Keidar-Friedman, D., Taube, R., & Lev, E. I. (2023) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-023-02891-x · Cited by 6 · see citing works

Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge

Guan, X., Verma, A. K., Wang, G., Shi, J., Perlman, S. M., & Du, L. (2023) · iScience · doi:10.1016/j.isci.2023.108033 · Cited by 6 · see citing works

Comparing COVID-19 severity in patients hospitalized for community-associated Delta, BA.1 and BA.4/5 variant infection

Sočan, M., Mrzel, M., Prosenc, K., Korva, M., Avšič‐Županc, T., Poljak, M., Lunar, M. M., & Zupanič, T. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1294261 · Cited by 6 · see citing works

Neurological diagnoses in hospitalized COVID ‐19 patients during the B.1.1.529 surge

Kim, C. Y., Sardar, Z., Ayele, B. A., Fleck‐Derderian, S., Barrett, C. E., Sun, Y., Clague, M., Hurst, H. A., Boruah, A. P., Zucker, J. E., et al. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51833 · Cited by 6 · see citing works

Application of Extracorporeal Apheresis in Treatment of COVID-19: a Rapid Review

Lezhnina, A., Lem, V., & Blatt, N. L. (2022) · BioNanoScience · doi:10.1007/s12668-022-00987-x · Cited by 5 · see citing works

A colorimetric reverse-transcription loop-mediated isothermal amplification method targeting the L452R mutation to detect the Delta variant of SARS-CoV-2

Thippornchai, N., Pengpanich, S., Jaroenram, W., Kosoltanapiwat, N., Sukphopetch, P., Kiatpathomchai, W., & Leaungwutiwong, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-72417-9 · Cited by 4 · see citing works

Analysis of Factors Influencing the Clinical Severity of Omicron and Delta Variants

Zhao, S., Luo, K., Guo, Y., Fang, M., Sun, Q., Dai, Z., Yang, H., Zhan, Z., Hu, S., Chen, T., et al. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8060330 · Cited by 4 · see citing works

Impact of Age and Variant Time Period on Clinical Presentation and Outcomes of Hospitalized Coronavirus Disease 2019 Patients

Srivastava, P. K., Klomhaus, A. M., Tehrani, D. M., Fonarow, G. C., Ziaeian, B., Desai, P. S., Rafique, A. M., de Lemos, J. A., Parikh, R. V., & Yang, E. H. (2023) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2023.07.004 · Cited by 4 · see citing works

Comparative outcomes of hemodialysis patients facing pre‐ Omicron and Omicron COVID ‐19 epidemics

Beppu, H., Fukuda, T., Otsubo, N., Akihisa, T., Kawanishi, T., Ogawa, T., Abe, Y., Endo, M., Hanawa, T., Sugita, C., et al. (2023) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.14067 · Cited by 4 · see citing works

A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoV

Guan, X., Verma, A. K., Wang, G., Roy, A., Perlman, S. M., & Du, L. (2024) · Vaccines · doi:10.3390/vaccines12060605 · Cited by 4 · see citing works

Lingering symptoms in non-hospitalized patients with COVID-19 – a prospective survey study of symptom expression and effects on mental health in Germany

Rohde, J., Bundschuh, R., Kaußner, Y., & Simmenroth, A. (2025) · BMC Family Practice · doi:10.1186/s12875-025-02784-3 · Cited by 4 · see citing works

Incidence and Severity of Postoperative Complications in Patients Undergoing Surgery Following COVID-19 Infection at a Tertiary Care Center in South India

Abraham, A. S., Sasikumar, N. K., Rajan, S., Abubaker, R., Manoharan, K. S., & Kumar, L. K. (2022) · Anesthesia Essays and Researches · doi:10.4103/aer.aer_134_22 · Cited by 4 · see citing works

A national risk analysis model (NRAM) for the assessment of COVID‐19 epidemic

Deng, Q., Xiao, X., Zhu, L., Cao, X., Liu, K., Zhang, H., Huang, L., Yu, F., Jiang, H., & Liu, Y. (2023) · Risk Analysis · doi:10.1111/risa.14087 · Cited by 4 · see citing works

Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection

Wu, Y., Pan, Y., Su, K., Zhang, Y., Jia, Z., Yi, J., Lv, H., Zhang, L., Xue, M., Cao, D., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1051104 · Cited by 4 · see citing works

Measures to Increase Immunogenicity of SARS-CoV-2 Vaccines in Solid Organ Transplant Recipients: A Narrative Review

Yu, B., Tamargo, C. L., Brennan, D. C., & Kant, S. (2023) · Vaccines · doi:10.3390/vaccines11121755 · Cited by 4 · see citing works

Differential severity of SARS-CoV-2 variant infections in children and adults with COVID-19

Brazer, N., Servellita, V., Jin, C., Foresythe, A., Oseguera, M., Nguyen, J., Sumimoto, N., Huh, H. J., Feder, A., Bhattacharya, S., et al. (2025) · Journal of Clinical Virology · doi:10.1016/j.jcv.2025.105833 · Cited by 3 · see citing works

Anti-nucleocapsid antibody levels reflect post-acute sequelae of COVID-19 symptom burden in children

Chen, P., Hsu, Y., Lin, C., Liu, X., Hsieh, M.-H., Tsai, H., Kuo, W., Kao, H.-F., Wang, S.-D., Ho, Y., et al. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.103020 · Cited by 3 · see citing works

Tracking temporal variations of fatality and symptomology correlated with COVID-19 dominant variants and vaccine effectiveness in the United States

Lin, S., Liu, H., Qi, Q., Ryan, I., Gao, D., Friedman, S., Xue, X. R., & Lawrence, D. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1419886 · Cited by 3 · see citing works

Evaluation Role of CXCL-8 levels and SARS-CoV-2 Variants in Progression of Infection

Salah, K. T., & Fadhil, H. Y. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.266039 · Cited by 3 · see citing works

Antimicrobial use in patients with confirmed COVID-19 infection: a cross-sectional study

Dominguez, R., Domingo-Cereno, N., & Josue-Dominguez, R. (2023) · Western Pacific surveillance response journal · doi:10.5365/wpsar.2023.14.2.999 · Cited by 5 · see citing works

From Alpha to Omicron and Beyond: Associations Between SARS-CoV-2 Variants and Surgical Outcomes

Verhagen, N. B., Geissler, T., SenthilKumar, G., Gehl, C. J., Shaik, T., Flitcroft, M. A., Yang, X., Taylor, B. W., Ghaferi, A. A., Gould, J. C., et al. (2024) · Journal of Surgical Research · doi:10.1016/j.jss.2024.05.034 · Cited by 3 · see citing works

Fusion protein-based COVID-19 vaccines exemplified by a chimeric vaccine based on a single fusion protein (W-PreS-O)

Gattinger, P., Kozlovskaya, L. I., Lunin, A. S., Gancharova, O. S., Sirazova, D. I., Apolokhov, V. D., Chekina, E. S., Gordeychuk, I. V., Karaulov, A. V., Valenta, R., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1452814 · Cited by 3 · see citing works

COVID-19 neurological manifestations - the experience of a tertiary hospital from Northeastern Romania

Diaconu, I. E. (2024) · The Medical-Surgical Journal · doi:10.22551/msj.2024.01.03 · Cited by 2 · see citing works

Severity of SARS‐CoV‐2 infection in pregnant women and their neonates during the Omicron period compared to the pre‐Omicron period: A retrospective cohort study

Yamaguchi, T., Makino, Y., Mabuchi, Y., Okuda, K., Hayashi, H., Kato, N., Fujii, T., & Hirate, H. (2023) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15610 · Cited by 2 · see citing works

Sensecor: A framework for COVID-19 variants severity classification and symptoms detection

Balaji, T., Bablani, A., Sreeja, S. R., & Misra, H. (2023) · Evolving Systems · doi:10.1007/s12530-023-09558-1 · Cited by 2 · see citing works

Healthcare policy for COVID ‐19 patients on haemodialysis: Adapting to the changing needs of the Omicron variant

Koh, D. X., Chen, J. J., Lee, M. Y. K., Tan, C. S., Tan, E. W. L., Chong, S. J., & Dan, Y. Y. (2022) · Nephrology · doi:10.1111/nep.14082 · Cited by 2 · see citing works

Study of Progression of COVID-19 in Indian Population based on Transcriptomic ApproachPreprint

Kshattry, M., Singh, S. D., Bharali, P., & Sastry, G. N. (2022) · Preprints.org · doi:10.20944/preprints202212.0431.v1 · Cited by 2 · see citing works

SARS-CoV-2 Omicron Infections among Vaccinated Maintenance Hemodialysis Patients: Outcomes and Comparison to Delta Variant

Wand, O., Drori, I., Einbinder, Y., Nacasch, N., Benchetrit, S., Breslavsky, A., & Cohen‐Hagai, K. (2024) · The Nephron journals/Nephron journals · doi:10.1159/000536521 · Cited by 1 · see citing works

COVID-19 pandemic – Cocktail of variants, a study from Northern India

Chaudhary, P. M., Gulati, N., Gupta, V., Garg, R., Walia, S., Dhawan, I., & Thakur, B. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1107_23 · Cited by 1 · see citing works

Three-Year Follow-Up of COVID-19 Cases in District of Constance, Germany. A Prospective, Controlled Cohort Study (FSC19-KN)

Kohler, A.-K., Richter, S., Schmid, M., Zimmermann, H., Winterer, H., Schneider, S., & Kollum, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051439 · Cited by 1 · see citing works

Predictors of health care utilization in patients with post-acute sequelae of COVID-19 (PASC)

Durant, E. J., Warton, E. M., Skarbinski, J., Siqueiros, M. H., Cholleti, S. M., Vinson, D. R., Mark, D. G., DiLena, D. D., Rauchwerger, A. S., Reed, M., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331370 · Cited by 1 · see citing works

SARS‐CoV‐2 Spike Protein‐Mediated Cardiac Dysfunction: Structural Abnormalities, Impaired Calcium Dynamics, and Gene Expression Changes in Human Stem Cell‐Derived Cardiomyocytes

Huang, C., Cheng, C. Y., Chen, S., Cheng, D., Wang, S.-H., Chao, C.-H., Lee, C., & Wang, J. (2026) · Journal of Medical Virology · doi:10.1002/jmv.70789 · Cited by 1 · see citing works

Racial and Ethnic Differences in COVID-19 Disease Severity Among US Adults in Health Systems Participating in PCORnet®

Simon‐Friedt, B., Koumans, E. H. A., Feehan, A. K., Trick, W. E., Draper, C., Denson, J. L., Nagavedu, K., Weiner, M., Rasmussen, S. A., Block, J. P., et al. (2026) · Medical Care · doi:10.1097/mlr.0000000000002221 · Cited by 1 · see citing works

Demographic and Clinical Presentation of Hospitalised Patients with SARS-CoV-2 During the First Omicron Wave

Patel, M., & Aitken, E. (2022) · European Medical Journal · doi:10.33590/emj/10174872 · Cited by 1 · see citing works

Refining Temporal Visualizations Using the Directional Coherence Loss

Poličar, P. G., & Zupan, B. (2023) · Lecture notes in computer science · doi:10.1007/978-3-031-45275-8_14 · Cited by 1 · see citing works

Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge

Bartalucci, C., Limongelli, A., Nicolini, L. A., Ponzano, M., Tigano, S., Farinella, S. T., Carrega, G., Malerba, G., Magnè, F., Balletto, E., et al. (2023) · Journal of Chemotherapy · doi:10.1080/1120009x.2023.2289269 · Cited by 1 · see citing works

Antibodies against SARS-CoV-2 in unvaccinated children hospitalized with COVID-19: An observational cohort study of pre-Omicron and Omicron variants era

Uppala, R., Sitthikarnkha, P., Faksri, K., Kosalaraksa, P., Techasatian, L., Tantawarak, N., & Nanthavongsa, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297991 · Cited by 1 · see citing works

Association between work sick-leave absenteeism and SARS-CoV-2 notifications in the Netherlands during the COVID-19 epidemic

Keet, M. G., Boudewijns, B., Jongenotter, F., van Iersel, S. C. J. L., van Werkhoven, C. H., van Gageldonk-Lafeber, R., Wisse, B. W., & van Asten, L. (2024) · European Journal of Public Health · doi:10.1093/eurpub/ckae051 · Cited by 1 · see citing works

The spatial–temporal variations and influencing factors of COVID-19 case fatality rate: a worldwide study in 30 countries from February 2021 to May 2022

Zhao, J., Huang, X., Li, X., Li, B., Rong, Z., Huang, X., Ren, R., Li, D., Li, C., Li, Q., et al. (2024) · Epidemiology and Infection · doi:10.1017/s0950268824000852 · Cited by 1 · see citing works

In Patients Hospitalized for Community-Acquired Pneumonia, SARS-CoV-2 Is Associated with Worse Clinical Outcomes When Compared to Influenza

Spindel, J., Furmanek, S. P., Chandler, T. R., Ramírez, J. A., & Cavallazzi, R. (2023) · Pathogens · doi:10.3390/pathogens12040571 · Cited by 1 · see citing works

Editorial: Innate immune responses to SARS-CoV-2 in infected and vaccinated individuals

Saksena, N. K., Reche, P. A., Bonam, S. R., & Mancini, N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1141405 · Cited by 1 · see citing works

Pathways to altered virulence of SARS-CoV-2Preprint

White, L. F., Egeren, D. V., Stoddard, M., D'Angelo, N., Bayly, H., Sagar, M., & Chakravarty, A. (2023) · doi:10.31219/osf.io/k4hb3 · Cited by 1 · see citing works

The Effect of Long COVID Syndrome Degree Severity on the Quality of Life of COVID-19 Survivors Aged 15-64 Years Old at Gotong Royong Hospital, Surabaya

Fernandez, E., Supit, P. A., & Suwasanti, N. (2023) · Asian Journal of Medicine and Health · doi:10.9734/ajmah/2023/v21i3798

Situation and Spatial Analysis of the COVID-19 Epidemic in Business Establishments: Comparison between the Delta and Omicron Variants in Thailand, July 2021–May 2022

Praekunatham, H., Buranasatitnon, S., & Ruksakom, H. (2022) · Outbreak Surveillance Investigation & Response (OSIR) Journal · doi:10.59096/osir.v15i4.262274

Fluorescent reverse transcription recombinase-aided amplification assay for sensitive and rapid detection of six respiratory virusesPreprint

Guo, X., Gao, D., Song, M., Yang, Y., Sun, D., Liu, W., Shi, H., Zhao, R., & Song, H. (2023) · doi:10.22541/au.168431232.21651511/v1

Post-COVID conditions during Delta and early-Omicron SARS-CoV-2 variant periods among adults in the United StatesPreprint

Edwards, D. L., Logan, P., Feldstein, L. R., Fairlie, T. A., Accorsi, E. K., & Saydah, S. (2023) · medRxiv · doi:10.1101/2023.08.09.23293776

Humoral Response Kinetics and Cross-Immunity in Hospitalized Patients with SARS-CoV-2 WT, Delta, or Omicron Infections: A Comparison between Vaccinated and Unvaccinated Cohorts

Kang, H., Lee, J., Jung, J. H., & Oh, E. (2023) · Vaccines · doi:10.3390/vaccines11121803

Overview and Outcomes of Patients Hospitalised with COVID-19 Pneumonia in Rīga East University Hospital

Rugājs, R., Madelāne, M., Ivanovs, A., & Vīksna, L. (2024) · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences · doi:10.2478/prolas-2024-0002

Epidemiological and transmission characteristics comparison analysis between Delta and Omicron variants of the SARS-CoV-2 (BA.2.1, BA.2.2, BA.2.76, BA.5.2)Preprint

Dai, Z., Luo, K., Liu, Q., Zhan, Z., Sun, Q., Lin, H., Chen, T., Zhao, Z., Li, X., & Liu, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-4135057/v1

Comparison of T cell maturation profiles in the 1st and 5th wave of COVID-19 in the Polish population

Rutkowska, E., Kwiecień, I., Raniszewska, A., Kłos, K., Melnicka, I., Rzepecki, P., & Chciałowski, A. (2024) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/186813

Supply-side Readiness of Primary Health Care for COVID-19 Pandemic Response in Indonesia: A Survey in 34 ProvincesPreprint

Fitrianingrum, N. M., Kamilah, F. Z., Larasanti, A., Saputra, M. A., Espressivo, A., & Herlinda, O. (2024) · Research Square · doi:10.21203/rs.3.rs-5272753/v1

The Role of Ursodeoxycholic Acid Administration During the COVID‐19 Pandemic: A Questionnaire Survey

Zhou, C., Jia, R., Yang, J. S. W., Liu, T., Liu, X., Yang, L., & Zhao, W. (2025) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/cjid/4601882

Additional file 1 of “It was almost like it’s set up for people to fail” A qualitative analysis of experiences and unmet supportive needs of people with Long COVID

McNabb, K. C., Bergman, A., Wright, R. S., Seltzer, J. L., Slone, S., Tomiwa, T., Alharthi, A., Davidson, P. M., Commodore-Mensah, Y. Y., & Ogungbe, O. (2023) · Figshare · doi:10.6084/m9.figshare.24465120

Investigation of Clinical Characteristics and Outcomes of COVID-19 across Successive Pandemic Waves: Evaluating the Impact of Vaccination among Hospitalized Patients in in Northern Iran-A Retrospective Cohort Study

Elyasi, S., Dabbaghi, F., & Mahmoudi, G. (2025) · “Polytechnic Bulletin” series “Engineering Research” · doi:10.61882/j.health.16.2.198

ПЕДІАТРИЧНИЙ LONG COVID: СУЧАСНІ АСПЕКТИ, ПАТОГЕНЕЗ, КЛІНІКА, ДІАГНОСТИКА, ЛІКУВАННЯ (ОГЛЯД ЛІТЕРАТУРИ ТА ВЛАСНЕ СПОСТЕРЕЖЕННЯ)

Конюшевская, А., Герасименко, В. В., Kuzevanova, M. V., & Сторожчук, Ю. О. (2025) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2025-4-179-32-56

Association between preoperative COVID-19 and major postoperative pulmonary complications: a multicentre observational cohort study in China

Wang, T., Lyu, Y., Zhang, H., Zhao, L., Wu, Y., Ma, Q., Yang, D., Zhang, R. T., Li, Z., Han, Y., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-110131

COVID vaccination and economic game decisions: The role of analytical thinking

Zher-Wen, Z.-W., & Yu, R. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2654307

Cross-neutralizing antibody responses among individuals with or without bivalent vaccine: a six-month prospective cohort study

Cha, H.-H., Kim, J. Y., Kim, S. B., Cha, J., Kwon, J.-S., Kim, W., Son, J. Y., Jang, C. Y., Lim, S. Y., Kim, S., et al. (2026) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2025.246

Death and ICU Admission Associated with Sars-Cov-2 Variants in Immunocompromised Hospitalised Individuals: A National Observational Study

Mattos, A. J. C., Mazon, F. J. N., dos Santos, L. F. T., Bianco, J., Monfardini, F., dos Santos, G. P., de Sousa, L. D., Sasse, M. M., Rizzo, L. V., Fonseca, H. A. R., et al. (2026) · Infectious Diseases and Therapy · doi:10.1007/s40121-026-01355-y

Analysis of the clinical characteristics of patients with COVID-19-related deaths during the two epidemic periods in a tertiary hospital in Wuhan, China: A retrospective study

Ding, J.-M., Li, M., Shen, M.-Y., Han, L., & Jin-bing, D. (2026) · Medicine · doi:10.1097/md.0000000000049397

Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients

Hu, F.-H., Jia, Y., Zhao, D., Fu, X.-L., Zhang, W., Tang, W., Hu, S.-Q., Wu, H. J., Ge, M.-W., Du, W., et al. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.03.017 · Cited by 89 · see citing works

COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar

Butt, A. A., Dargham, S. R., Tang, P., Chemaitelly, H. S., Hasan, M. R., Coyle, P. V., Kaleeckal, A. H., Latif, A. N., Loka, S., Shaik, R. M., et al. (2022) · Journal of Global Health · doi:10.7189/jogh.12.05032 · Cited by 58 · see citing works

Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants

Esper, F. P., Adhikari, T. M., Tu, Z. J., Cheng, Y., El-Haddad, K., Farkas, D. H., Bosler, D. S., Rhoads, D. D., Procop, G. W., Ko, J. S., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac411 · Cited by 154 · see citing works

The risk of mortality and severe illness in patients infected with the omicron variant relative to delta variant of SARS-CoV-2: a systematic review and meta-analysis

Kow, C. S., Ramachandram, D. S., & Hasan, S. S. (2023) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-022-03266-6 · Cited by 10 · see citing works

Clinical Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Relative to Delta in British Columbia, Canada: A Retrospective Analysis of Whole-Genome Sequenced Cases

Harrigan, S. P., Wilton, J., Chong, M., Abdia, Y., García, H. A. V., Rose, C., Taylor, M., Mishra, S., Sander, B., Hoang, L., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac705 · Cited by 25 · see citing works